Gastroenteritis

50 treatments and conditions followed through the public trial records. Not medical advice.How a status is set

Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.

Treatments and conditions

Gastroenteritis
Treatment and conditionWhere it standsTrials
AC-101 for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Adalimumab-800CW + Fluorescence Imaging for inflammatory bowel diseasesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Alginos Oral Suspension for esophagitisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Anaprazole + Rabeprazole placebo for esophagitis, pepticPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
ATG + CliniMACS® TCR α/β Reagent Kit and CliniMACS® CD19 System + Prednisone/Methylprenisolone + Total Body Irradiation + RITUXIMAB + CLOFARABINE + Melphalan + PALIFERMIN for crohn diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Atorvastatin calcium trihydrate for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
AZD7798 for crohn diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Bezlotoxumab for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Bezlotoxumab for crohn diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Brivekimig for crohn diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Curcumin for gastritis, atrophicPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Duvakitug for colitis, ulcerativePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Emvistegrast for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Fecal Microbial Transplantation for colitis, ulcerativePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Fecal microbiota for colitisTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Fecal Microbiota Transplantation for inflammatory bowel diseasesPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Fluconazole for crohn diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Fluorescence Imaging for inflammatory bowel diseasesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Golimumab for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Guselkumab for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Guselkumab for crohn diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
H021 Enteric-coated Tablets High-dose Group for crohn diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
H021 Enteric-coated Tablets Low-dose Group for crohn diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
High dose Recombinant Trivalent Subunit Rotavirus Vaccine for gastroenteritisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Infliximab for colitisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Infliximab for crohn diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)2
infliximab (IFX) infusion; azathioprine (AZA) caps for crohn diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
infliximab (IFX) placebo infusion; azathioprine (AZA) caps for crohn diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
INT-210 Capsule for colitis, ulcerativePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Intermittent Reduced Calorie Diet (IRCD) for crohn diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
JNJ-78934804 for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
local co-administration of autologous ADIpose for crohn diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Mid dose Recombinant Trivalent Subunit Rotavirus Vaccine for gastroenteritisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Mirikizumab for colitis, ulcerativePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Obefazimod for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
PALI-2108 for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Phentermine-Topiramate for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo for crohn diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo-to-match emvistegrast + Emvistegrast for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Risankizumab for crohn diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
single FMT for colitis, ulcerativePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
SPY001 for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
SPY001 + SPY002 for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
SPY001 + SPY003 for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
SPY002 for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
SPY002 + SPY003 for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
SPY003 for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
Vedolizumab for colitisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Vedolizumab for colitis, ulcerativePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Vedolizumab for crohn diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1